These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2659797)

  • 1. A novel replicating agent isolated from the human intestinal tract having characteristics shared with Creutzfeldt-Jakob and related agents.
    Burdon DW
    J Med Microbiol; 1989 Jun; 29(2):145-57. PubMed ID: 2659797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of a novel agent possessing resistance to moist heat and disinfectants: parallels with Creutzfeldt-Jakob agent.
    Dyas AC; Burdon DW
    J Hosp Infect; 1990 Apr; 15(3):265-72. PubMed ID: 1971633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an unconventional virus in mouse-adapted Creutzfeldt-Jakob disease.
    Kingsbury DT; Smeltzer DA; Amyx HL; Gibbs CJ; Gajdusek DC
    Infect Immun; 1982 Sep; 37(3):1050-3. PubMed ID: 6752018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditions for the chemical and physical inactivation of the K. Fu. strain of the agent of Creutzfeldt-Jakob disease.
    Walker AS; Inderlied CB; Kingsbury DT
    Am J Public Health; 1983 Jun; 73(6):661-5. PubMed ID: 6342430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.
    Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S
    Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical disinfection of Creutzfeldt-Jakob disease virus.
    Brown P; Gibbs CJ; Amyx HL; Kingsbury DT; Rohwer RG; Sulima MP; Gajdusek DC
    N Engl J Med; 1982 May; 306(21):1279-82. PubMed ID: 7040968
    [No Abstract]   [Full Text] [Related]  

  • 7. [Creutzfeld-Jakob disease: recent advances; biology of unconventional viruses (author's transl)].
    Cathala F; Moreau-Dubois MC; Brown P
    Pathol Biol (Paris); 1980 Oct; 28(8):545-53. PubMed ID: 6776473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Creutzfeldt Jakob disease. Recommended precautions for patient management and diagnostic procedures (author's transl)].
    Brown P; Cathala F; Gajdusek DC
    Rev Neurol (Paris); 1978 Apr; 134(4):277-86. PubMed ID: 364589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precautions in medical care of, and in handling materials from, patients with transmissible virus dementia (Creutzfeldt-Jakob disease).
    Gajdusek DC; Gibbs CJ; Asher DM; Brown P; Diwan A; Hoffman P; Nemo G; Rohwer R; White L
    N Engl J Med; 1977 Dec; 297(23):1253-8. PubMed ID: 335248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease with demonstration of virus-like particles.
    Shibayama Y; Sakaguchi Y; Nakata K; Goto T; Nakai M; Takai T; Shirakata S
    Acta Pathol Jpn; 1982 Jul; 32(4):695-702. PubMed ID: 7051752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between slow virus infection of animals and man, their pathogenicity and resistance to therapy].
    Frýdl V
    Fortschr Neurol Psychiatr; 1988 Jun; 56(6):186-92. PubMed ID: 3136063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Properties of the causative agent of Creutzfeldt-Jakob disease; current insights into the pathogenesis of dementia].
    van der Waals FW; Goudsmit J
    Ned Tijdschr Geneeskd; 1985 Jul; 129(27):1275-80. PubMed ID: 3897875
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice.
    Sakaguchi S; Katamine S; Yamanouchi K; Kishikawa M; Moriuchi R; Yasukawa N; Doi T; Miyamoto T
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2117-23. PubMed ID: 8409936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tateishi J; Tashima T; Kitamoto T
    Ann Neurol; 1988 Sep; 24(3):466. PubMed ID: 3067656
    [No Abstract]   [Full Text] [Related]  

  • 15. Creutzfeldt-Jakob disease prion proteins in human brains.
    Bockman JM; Kingsbury DT; McKinley MP; Bendheim PE; Prusiner SB
    N Engl J Med; 1985 Jan; 312(2):73-8. PubMed ID: 3917302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of prion inactivation comparing steam sterilization and chemical sterilants: proposed method for test standardization.
    Vadrot C; Darbord JC
    J Hosp Infect; 2006 Oct; 64(2):143-8. PubMed ID: 16895739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Kuru, Creutzfeldt-Jakob, and scrapie.
    Lancet; 1974 Dec; 2(7896):1551-2. PubMed ID: 4140986
    [No Abstract]   [Full Text] [Related]  

  • 18. Scrapie and Creutzfeldt-Jakob disease prions.
    Prusiner SB; Barry RA; McKinley MP; Bellinger CG; Meyer RK; DeArmond SJ; Kingsbury DT
    Microbiol Sci; 1985; 2(2):33-9. PubMed ID: 3940147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prion, from crazy cows to iatrogenic Creutzfeldt-Jakob disease. Which risk in laboratory or in hospital?].
    Paul J
    Pathol Biol (Paris); 1995 Feb; 43(2):114-20. PubMed ID: 7777380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tamai Y; Taguchi F; Miura S
    Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.